Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals.

Koziorowski, J; Behe, M; Decristoforo, C; Ballinger, J; Elsinga, P; Ferrari, V; Kolenc Peitl, P; Todde, S; Mindt, T L

Koziorowski, J; Behe, M; Decristoforo, C; Ballinger, J; Elsinga, P; Ferrari, V; Kolenc Peitl, P; Todde, S; Mindt, T L.

Afiliação

Koziorowski J; Department of Radiation Physics and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
Behe M; Center for Radiopharmaceutical Sciences ETH-PSI-USZ Paul-Scherrer-Institute, 5232 Villigen-PSI, Switzerland.
Decristoforo C; Department of Nuclear Medicine, Medical University Innsbruck, 6020 Innsbruck, Austria.
Ballinger J; Guy's and St Thomas' Hospital, London, SE1 9RT UK.
Elsinga P; University Medical Center, University of Groningen, 9700 RB Groningen, Netherlands.
Ferrari V; GE Healthcare, Amersham, UK.
Kolenc Peitl P; University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Todde S; Università di Milano-Bicocca, Tecnomed Foundation, 20090 Monza, Italy.
Mindt TL; University of Basel Hospital, Radiopharmaceutical Chemistry, 4031 Basel, Switzerland.

EJNMMI Radiopharm Chem ; 1(1): 1, 2017.

Article em En | MEDLINE | ID: mdl-29564378

Palavras-chave

Position paper; Pre-clinical toxicology studies; Radiopharmaceuticals

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJNMMI Radiopharm Chem Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google